Literature DB >> 25411513

Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis).

Raymond S Douglas1, Tünde Mester2, Anna Ginter2, Denise S Kim2.   

Abstract

PURPOSE: To better understand the pathogenesis of thyroid-associated orbitopathy (TAO) through elucidating the role of thyrotropin receptor (TSHR) and CD40 in the expression of interleukin-8 (IL-8) in peripheral blood fibrocytes. Fibrocytes infiltrate the orbit of patients with TAO, where they differentiate into fibroblasts. Fibrocyte precursors occur with increased frequency in the peripheral blood expressing TSHR and CD40 in TAO patients. We hypothesize that in vitro derived fibrocytes and peripheral blood fibrocyte precursors express proinflammatory chemoattractant molecules including IL-8 initiated by TSHR and CD40 signaling. Since nearly all TAO patients express activating antibodies to TSHR, this is particularly relevant for activation of peripheral blood fibrocytes.
METHODS: TSHR and CD40 expression on peripheral blood fibrocytes was determined by flow cytometry. IL-8 RNA was quantitated by real-time polymerase chain reaction. IL-8 protein production was measured by Luminex and flow cytometry. Thyroid-stimulating hormone and CD40 ligand-stimulated phosphorylation of Akt in peripheral blood fibrocytes was studied by flow cytometry.
RESULTS: Both TSHR- and CD40-mediated signaling lead to IL-8 expression in mature fibrocytes. Fibrocyte precursors assayed directly from circulating peripheral blood demonstrate intracellular IL-8 expression with addition of thyroid-stimulating hormone or CD40 ligand. TSHR- and CD40-induced IL-8 production is mediated by Akt phosphorylation.
CONCLUSIONS: Peripheral blood TSHR(+) and CD40(+) fibrocytes express IL-8 and may promote the recruitment of inflammatory cells, mitogenesis, and tissue remodeling in TAO. TSHR- and CD40-mediated IL-8 signaling is mediated by Akt. Delineating the molecular mechanisms of fibrocyte immune function may provide potential therapeutic targets for TAO.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25411513      PMCID: PMC4234450     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  72 in total

Review 1.  Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

Authors:  Casey T Weaver; Robin D Hatton
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

2.  Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease.

Authors:  Shanli Tsui; Roshini Fernando; Beiling Chen; Terry J Smith
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

3.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

Authors:  J Chesney; M Bacher; A Bender; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 4.  New and future immunomodulatory therapy in type 1 diabetes.

Authors:  James E Tooley; Frank Waldron-Lynch; Kevan C Herold
Journal:  Trends Mol Med       Date:  2012-02-17       Impact factor: 11.951

Review 5.  Roles of IL-8 in ocular inflammations: a review.

Authors:  Hassan Ghasemi; Tooba Ghazanfari; Roya Yaraee; Soghrat Faghihzadeh; Zuhair Mohammad Hassan
Journal:  Ocul Immunol Inflamm       Date:  2011-12       Impact factor: 3.070

Review 6.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

7.  Increased generation of fibrocytes in thyroid-associated ophthalmopathy.

Authors:  Raymond S Douglas; Nikoo F Afifiyan; Catherine J Hwang; Kelvin Chong; Uzma Haider; Patrick Richards; Andrew G Gianoukakis; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-11-06       Impact factor: 5.958

Review 8.  Role of connective tissue autoimmunity in Graves' ophthalmopathy.

Authors:  R S Bahn; A E Heufelder
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

9.  Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood.

Authors:  L E DeForge; D G Remick
Journal:  Biochem Biophys Res Commun       Date:  1991-01-15       Impact factor: 3.575

Review 10.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

View more
  5 in total

Review 1.  2021 update on thyroid-associated ophthalmopathy.

Authors:  E J Neag; T J Smith
Journal:  J Endocrinol Invest       Date:  2021-08-20       Impact factor: 5.467

2.  Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.

Authors:  M Nowak; L Siemińska; J Karpe; B Marek; B Kos-Kudła; D Kajdaniuk
Journal:  J Endocrinol Invest       Date:  2015-06-11       Impact factor: 4.256

3.  CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation.

Authors:  Tünde Mester; Nupur Raychaudhuri; Erin F Gillespie; Hong Chen; Terry J Smith; Raymond S Douglas
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

Review 4.  The emerging role of fibrocytes in ocular disorders.

Authors:  Feng Zhang; Ke Liu; Han Zhao; Yan He
Journal:  Stem Cell Res Ther       Date:  2018-04-13       Impact factor: 6.832

5.  Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy.

Authors:  Edina Kishazi; Marianne Dor; Simone Eperon; Aurélie Oberic; Natacha Turck; Mehrad Hamedani
Journal:  Sci Rep       Date:  2018-07-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.